Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Bioscience Fund Transfer topic
No spam. Unsubscribe anytime.
Appropriations committee moves $1.03 million from bioscience grant fund to general fund in HB1009
Summary
The Senate Appropriations Committee reconsidered House Bill 1009, adopted an amendment to transfer $1,029,000 from the Bioscience Innovation Grant Fund to the General Fund, and gave the bill a due-pass recommendation by unanimous recorded votes (16-0).
The Senate Appropriations Committee on Thursday reconsidered its prior action on House Bill 1009 and approved an amendment that transfers an unspent balance in the Bioscience Innovation Grant Fund to the General Fund. Committee members recorded unanimous approval at multiple recorded votes following reconsideration.
Committee discussion centered on a provision added to the bill that directs the Office of Management and Budget to transfer any remaining balance in the Bioscience Innovation Grant Fund to the General Fund on June 30, 2025. Committee members identified the unspent balance as $1,029,000 and said the amendment prevents initiating another round of bioscience grants in the current biennium so the legislature can consider restructuring the program in a future session.
A senator who previously sponsored a bill to repeal the bioscience innovation program told the committee the earlier repeal failed; the amendment is a temporary measure to remove remaining funds from active grantmaking while the legislature reconsiders the program’s structure. Committee counsel explained that after the committee’s reconsideration, the newly adopted amendment replaces the prior amendment language and is the version the committee advanced.
The committee voted to reconsider its prior action on HB1009, then adopted the amendment on the record and gave the bill a due-pass recommendation as amended; each recorded vote passed 16-0. The committee assigned a carrier to take the bill to the floor.
